The age of transcatheter aortic valve replacement started in 1985. Since then, hundreds of thousands of valves have been placed by the transcatheter approach. As these valves age and eventually fail, they will need to be replaced. One of the evolving challenges in the medical field of structural heart is the ability to place a transcatheter heart valve inside a previously placed cardiac valve.
Furthermore, the placement of a transcatheter valve inside even a native valve can be, at times, challenging due to cardiac anatomy.
Often the major obstacle is the displacement of the existing valve leaflets to a position obstructing the origin of the coronary arteries. Obstruction of coronary blood flow can be rapidly catastrophic. Valve leaflets blocking or even partially blocking coronary catheter access can likewise have dire consequences for the patient.
The present options to alleviate this valve leaflet problem have been very limited, difficult, and with substantial risk to the patient.
A valve cutter provides a percutaneous option for making cuts in the original leaflets of an existing cardiac valve, which may be an artificial or native valve. Longitudinal cuts in the valve leaflets open up a path for both blood flow and catheter access into the coronary arteries.
A replacement procedure includes two main steps: the cutting of the original leaflets of the existing aortic valve and the placement of a replacement valve within the native or previously placed aortic valve. Percutaneous vascular access is first obtained. This access is usually via the femoral artery with a large bore sheath. A guidewire is placed from the sheath across the aortic valve into the left ventricle. Over the guidewire, the valve cutter is loaded and advanced into the aortic valve. Vertical cuts are made in the three leaflets of the aortic valve. The valve cutter is then exchanged over the guidewire for the replacement valve. This replacement valve is advanced over the guidewire until it is positioned inside the existing aortic valve. The replacement valve is then deployed inside the existing valve.
A replacement valve is specifically designed for the replacement procedure of an existing valve. The replacement valve is placed from percutaneous access. The basic structure of the replacement valve is a self-expanding nitinol frame. The replacement valve is compressed on a delivery catheter and expanded with the retraction of an outer sheath. Three control wires with a self-releasing or screw connection tether the replacement valve to the valve delivery catheter.
The replacement procedure with leaflet inversion opens up an access window where the original leaflets would normally obstruct blood flow and catheter access to the coronary arteries. This procedure involves making one or more longitudinal cuts in some or each of the original leaflets. Once the original leaflets are cut, the replacement valve can be placed within the existing valve. The replacement valve is then positioned just above the existing valve. The leaflet commissures of the replacement valve and the existing valve are aligned. The replacement valve is allowed to expand to a point of close proximity or lightly touching the inner margins of the existing valve. The replacement valve is then pushed down into the existing valve. When the replacement valve is pushed down into the existing valve, the original leaflets, which are cut, are moved inferiorly toward the left ventricle. This maneuver opens up windows in the existing valve that are free from leaflet blockage. If the existing valve is a transcatheter valve, the windows are where the cut leaflets are pushed away from the sides of the existing valve, and are no longer against the frame (or wall) of the existing valve. In some biological surgical valves, the windows are where the cut leaflets are pushed away from the coronary ostium. These unobstructed windows allow coronary blood flow and catheter access. The inferior edge of the replacement valve is positioned at or just slightly beyond the inferior edge of the existing valve. At this point, x-ray dye can be injected just above the valves to confirm free blood flow into the coronary arteries and proper position of the replacement valve. If the position is not ideal, the replacement valve can be recaptured within the sheath of the delivery catheter. A repeat positioning can then be done prior to full expansion and release of the replacement valve.
For a more detailed description of the embodiments of the disclosure, reference will now be made to the accompanying drawings, wherein:
The replacement valve 100 has several new design features that allow it to function in this new procedure.
The replacement valve 100 is designed with three large cells 10 and three medium cells 12 at the upper portion 22 of a nitinol frame. These cells 10, 12 may be open and shaped like hexagons. The large cells 10 minimize the difficulty in placing a catheter into the coronary arteries. Two of the large cells will be placed in front of, or aligned with, coronary artery ostium. The nitinol frame is made stiff by using heavy gauge nitinol. The nitinol frame allows compression of the original leaflets of the existing valve between the existing valve and the frame of the replacement valve 100.
The inferior edge 28 of the nitinol frame may or may not be covered with a fabric skirt 20 (shown in
The inferior edge 28 of the nitinol frame is engineered with several new design features. The arm length of the bottom half of the inferior row 30 of cells, which may be shaped like diamonds, is shorter than the arm length in the upper half of the cell. This cell arm length differential results in a flat or nearly flat inferior edge 28 when the replacement valve 100 is fully expanded.
The lower tip at the intersection of the two shorter arms on the inferior edge 28 of the replacement valve 100 is rounded out so that when the replacement valve 100 is expanded, a smooth bump and not a corner point is created. The leading nitinol edges on the bottom portion 24 of the nitinol frame are smooth and present a decreased sliding resistance when pushing down on the original leaflets of the existing valve.
Referring back to
The height of the replacement valve 100 is less than the height of most of the presently used self-expanding valves. This replacement valve 100 can extend over an area that only covers the inner length of the existing valve in the aortic annular area. The surgical biologic valves and balloon deployed transcatheter valves have a lower height than self-expanding valves. The height of the replacement valve 100 is nevertheless sufficient for use with a surgical biologic valve and balloon. There can be various sizes of the replacement valve 100. The sizes can vary in diameter and height.
Another feature to this replacement valve 100 is three vertical posts 14 that extend from the inferior edge 28 (illustrated in
The three vertical posts 14 are where the valve delivery wires 102 attach to the replacement valve 100. At the top end 16 of the vertical posts 14, the diameter may be slightly increased in a pod-like configuration. This localized increased diameter will not only strengthen the joint, but aid in valve recapture by the sheath. In other embodiments, the top ends of the vertical posts may be flush with the top rim of the valve.
The replacement valves and the replacement procedures with leaflet inversion described herein provide a new and novel way to overcome the problem of the valve leaflet obstruction of coronary blood flow and obstruction of catheter access in the aortic valve. These replacement valves and replacement procedures with leaflet inversion offer a relatively simple solution to a pressing and complex problem that is now present in the structural heart field of cardiology. It is believed that by using the valve cutter along with the specifically designed replacement valves described herein, the leaflet-coronary obstruction problem can be resolved in most cases.
Specific embodiments of the invention are shown by way of example in the drawings and description. It should be understood, however, that the drawings and detailed description thereto are not intended to limit the claims to the particular form disclosed, but on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the scope of the claims.
This application claims the benefit of priority to U.S. provisional application Ser. No. 63/074,860 filed on Sep. 4, 2020, which is incorporated herein by reference for all or any purposes.
Number | Name | Date | Kind |
---|---|---|---|
9180005 | Lashinski | Nov 2015 | B1 |
9393115 | Tabor | Jul 2016 | B2 |
9566178 | Cartledge | Feb 2017 | B2 |
9750603 | Bell | Sep 2017 | B2 |
9848983 | Lashinski | Dec 2017 | B2 |
9907681 | Tobis | Mar 2018 | B2 |
10278820 | Bar | May 2019 | B2 |
11185405 | Girard | Nov 2021 | B2 |
11197754 | Saffari | Dec 2021 | B2 |
11337800 | Schreck | May 2022 | B2 |
11357624 | Guyenot | Jun 2022 | B2 |
11523905 | Griswold | Dec 2022 | B2 |
11589981 | Girard | Feb 2023 | B2 |
11737876 | Anderson | Aug 2023 | B2 |
20020161377 | Rabkin | Oct 2002 | A1 |
20040186565 | Schreck | Sep 2004 | A1 |
20040260394 | Douk | Dec 2004 | A1 |
20050137686 | Salahieh | Jun 2005 | A1 |
20050137699 | Salahieh | Jun 2005 | A1 |
20070088431 | Bourang | Apr 2007 | A1 |
20070203503 | Salahieh | Aug 2007 | A1 |
20080195199 | Kheradvar | Aug 2008 | A1 |
20100152838 | Kang | Jun 2010 | A1 |
20100249920 | Bolling | Sep 2010 | A1 |
20110224785 | Hacohen | Sep 2011 | A1 |
20110264191 | Rothstein | Oct 2011 | A1 |
20110288632 | White | Nov 2011 | A1 |
20120022640 | Gross | Jan 2012 | A1 |
20130046373 | Cartledge | Feb 2013 | A1 |
20130150956 | Yohanan | Jun 2013 | A1 |
20130310923 | Kheradvar | Nov 2013 | A1 |
20140121763 | Duffy | May 2014 | A1 |
20160158003 | Wallace | Jun 2016 | A1 |
20160213467 | Backus | Jul 2016 | A1 |
20160220365 | Backus | Aug 2016 | A1 |
20160367360 | Cartledge | Dec 2016 | A1 |
20170042671 | Backus | Feb 2017 | A1 |
20170049563 | Straubinger | Feb 2017 | A1 |
20170128198 | Cartledge | May 2017 | A1 |
20170231765 | Desrosiers | Aug 2017 | A1 |
20170325951 | Escalona | Nov 2017 | A1 |
20180325665 | Gurovich | Nov 2018 | A1 |
20200000590 | Salahieh | Jan 2020 | A1 |
20200188099 | Dvorsky | Jun 2020 | A1 |
20200360134 | Peterson | Nov 2020 | A1 |
Number | Date | Country | |
---|---|---|---|
20220071764 A1 | Mar 2022 | US |
Number | Date | Country | |
---|---|---|---|
63074860 | Sep 2020 | US |